Lysosomal iron, iron chelation, and cell death

Antioxidants and Redox Signaling

Volumn 18, Issue 8, 2013, Pages 888-898

  Terman, Alexei ^a   Kurz, Tino ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2,9 DIMETHYL 1,10 PHENANTHROLINE; 3 HYDROXY 2 METHYL 1 PROPYL 4 PYRIDONE; CHELATING AGENT; COPPER CHELATING AGENT; CP 22; CYTOSTATIC AGENT; DEFEROXAMINE; DIETHYLDITHIOCARBAMIC ACID; FERROUS ION; HYDROLASE; HYDROXYL RADICAL; IRON CHELATING AGENT; SALICYLALDEHYDE ISONICOTINOYLHYDRAZONE; UNCLASSIFIED DRUG;

AGING; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; AUTOPHAGY; BIOACCUMULATION; BIODEGRADATION; CATALYST; CELL DAMAGE; CELL DEATH; DRUG SENSITIVITY; ENDOCYTOSIS; ENZYME RELEASE; FENTON REACTION; HUMAN; IRON CHELATION; IRON DEPLETION; IRON METABOLISM; IRON OVERLOAD; LYSOSOME; LYSOSOME MEMBRANE; MACROMOLECULE; MEMBRANE DAMAGE; NERVE DEGENERATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW;

APOPTOSIS; CELL DEATH; HUMANS; IRON; IRON CHELATING AGENTS; LYSOSOMES; OXIDATIVE STRESS;

EID: 84871061522     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4885     Document Type: Review

References (91)

1. Ahlberg J, Marzella L, and Glaumann H. Uptake and degradation of proteins by isolated rat liver lysosomes. Suggestion of a microautophagic pathway of proteolysis. Lab Invest 47: 523-532, 1982.
2. 2 is a consequence of lysosomal rupture. Biochem J 356: 549-555, 2001.
3. Arnold I and Langer T. Membrane protein degradation by AAA proteases in mitochondria. Biochim Biophys Acta 1592: 89-96, 2002.
4. Asano T, Komatsu M, Yamaguchi-Iwai Y, Ishikawa F, Mi-zushima N, and Iwai K. Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol Cell Biol 31: 2040-2052, 2011.
5. Baird SK, Kurz T, and Brunk UT. Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem J 394: 275-283, 2006.
6. Bakala H, Delaval E, Hamelin M, Bismuth J, Borot-Laloi C, Corman B, and Friguet B. Changes in rat liver mitochondria with aging. Lon protease-like reactivity and N(epsilon)-carboxymethyllysine accumulation in the matrix. Eur J Bio-chem 270: 2295-2302, 2003.
7. Baumgartner HK, Gerasimenko JV, Thorne C, Ashurst LH, Barrow SL, Chvanov MA, Gillies S, Criddle DN, Tepikin AV, Petersen OH, Sutton R, Watson AJ, and Gerasimenko OV. Caspase-8-mediated apoptosis induced by oxidative stress is independent of the intrinsic pathway and dependent on cathepsins. Am J Physiol Gastrointest Liver Physiol 293: G296-G307, 2007.
8. Bergamini E. Autophagy: a cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically. Mol Aspects Med 27: 403-410, 2006.
9. Berndt C, Kurz T, Selenius M, Fernandes AP, Edgren MR, and Brunk UT. Chelation of lysosomal iron protects against ionizing radiation. Biochem J 432: 295-301, 2010.
10. Bertini I, Lalli D, Mangani S, Pozzi C, Rosa C, Theil EC, and Turano P. Structural insights into the ferroxidase site of ferritins from higher eukaryotes. J Am Chem Soc 134: 6169-6176, 2012.
11. Brunk UT, Neuzil J, and Eaton JW. Lysosomal involvement in apoptosis. Redox Rep 6: 91-97, 2001.
12. Brunk UT and Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep 4: 3-11, 1999.
13. Brunk UT and Terman A. Lipofuscin: Mechanisms of age-related accumulation and influence on cell functions. Free Radic Biol Med 33: 611-619, 2002.
14. Brunk UT and Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 269: 1996-2002, 2002.
15. Chen D, Cui QC, Yang H, and Dou QP. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res 66: 10425-10433, 2006.
16. Chen SH, Lin JK, Liu SH, Liang YC, and Lin-Shiau SY. Apoptosis of cultured astrocytes induced by the copper and neocuproine complex through oxidative stress and JNK activation. Toxicol Sci 102: 138-149, 2008.
17. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, Salvesen GS, and Turk B. Selective disruption of lyso-somes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279: 3578-3587, 2004.
18. Codogno P, Mehrpour M, and Proikas-Cezanne T. Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol 13: 7-12, 2012.
19. Cuervo AM, Bergamini E, Brunk UT, Droge W, Ffrench M, and Terman A. Autophagy and aging: the importance of maintaining "clean" cells. Autophagy 1: 131-140, 2005.
20. De Domenico I, Ward DM, and Kaplan J. Specific iron che-lators determine the route of ferritin degradation. Blood 114: 4546-4551, 2009.
21. de Souza W, Sant'Anna C, and Cunha-e-Silva NL. Electron microscopy and cytochemistry analysis of the endocytic pathway of pathogenic protozoa. Prog Histochem Cytochem 44: 67-124, 2009.
22. Denton D, Nicolson S, and Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death Differ 19: 87-95, 2012.
23. Dong XP, Cheng X, Mills E, Delling M, Wang F, Kurz T, and Xu H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455: 992-996, 2008.
24. Dunaief JL. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci 47: 4660-4664, 2006.
25. Eaton JW and Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 32: 833-840, 2002.
26. Eskelinen EL, Prescott AR, Cooper J, Brachmann SM, Wang L, Tang X, Backer JM, and Lucocq JM. Inhibition of autop-hagy in mitotic animal cells. Traffic 3: 878-893, 2002.
27. Galluzzi L, Vanden Berghe T, Vanlangenakker N, Buettner S, Eisenberg T, Vandenabeele P, Madeo F, and Kroemer G. Programmed necrosis from molecules to health and disease. Int Rev Cell Mol Biol 289: 1-35, 2011.
28. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, and Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19: 107-120, 2012.
29. Garner B, Roberg K, and Brunk U. Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress. Free Radic Res 29: 103-104, 1998.
30. Green DR, Galluzzi L, and Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333: 1109-1112, 2011.
31. Gupte A and Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev 35: 32-46, 2009.
32. Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, Efferth T, Eils R, and Brady NR. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem 286: 6587-6601, 2011.
33. Hengartner MO. The biochemistry of apoptosis. Nature 407: 770-776, 2000.
34. Jolly RD, Douglas BV, Davey PM, and Roiri JE. Lipofuscin in bovine muscle and brain: a model for studying age pigment. Gerontology 41: 283-295, 1995.
35. Kar P, Samanta K, Shaikh S, Chowdhury A, Chakraborti T, and Chakraborti S. Mitochondrial calpain system: an overview. Arch Biochem Biophys 495: 1-7, 2010.
36. Kaushik S and Cuervo AM. Autophagy as a cell-repair mechanism: activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 27: 444-454, 2006.
37. Kidane TZ, Sauble E, and Linder MC. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 291: C445-C455, 2006.
38. Kirkegaard T and Jäättelä M. Lysosomal involvement in cell death and cancer. Biochim Biophys Acta 1793: 746-754, 2009.
39. Kovacevic Z, Kalinowski DS, Lovejoy DB, Yu Y, Suryo Rahmanto Y, Sharpe PC, Bernhardt PV, and Richardson DR. The medicinal chemistry of novel iron chelators for the treatment of cancer. Curr Top Med Chem 11: 483-499, 2011.
40. Kroemer G, Marino G, and Levine B. Autophagy and the integrated stress response. Mol Cell 40: 280-293, 2010.
41. Kurz T and Brunk UT. Autophagy of HSP70 and chelation of lysosomal iron in a non-redox-active form. Autophagy 5: 93-95, 2009.
42. Kurz T, Eaton JW, and Brunk UT. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol 43: 1686-1697, 2011.
43. Kurz T, Gustafsson B, and Brunk UT. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J 273: 3106-3117, 2006.
44. Kurz T, Gustafsson B, and Brunk UT. Cell sensitivity to oxidative stress is influenced by ferritin autophagy. Free Radic Biol Med 50: 1647-1658, 2011.
45. Kwok JC and Richardson DR. Examination of the mecha-nism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol Pharmacol 65: 181-195, 2004.
46. Li WW, Li J, and Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci 69: 1125-1136, 2012.
47. Liu X, Jin W, and Theil EC. Opening protein pores with chaotropes enhances Fe reduction and chelation of Fe from the ferritin biomineral. Proc Natl Acad Sci USA 100: 3653-3658, 2003.
48. Lovejoy DB, Jansson PJ, Brunk UT, Wong J, Ponka P, and Richardson DR. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes. Cancer Res 71: 5871-5880, 2011.
49. Luzio JP, Pryor PR, and Bright NA. Lysosomes: fusion and function. Nat Rev Mol Cell Biol 8: 622-632, 2007.
50. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R, and Kroemer G. Control of autophagy by on-cogenes and tumor suppressor genes. Cell Death Differ 16: 87-93, 2009.
51. Mindell JA. Lysosomal acidification mechanisms. Annu Rev Physiol 74: 69-86, 2012.
52. Mizushima N and Komatsu M. Autophagy: renovation of cells and tissues. Cell 147: 728-741, 2011.
53. Mizushima N, Yoshimori T, and Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27: 107-132, 2011.
54. Morel I, Cillard J, Lescoat G, Sergent O, Pasdeloup N, Ocaktan AZ, Abdallah MA, Brissot P, and Cillard P. Anti-oxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. Free Radic Biol Med 13: 499-508, 1992.
55. Mullins C and Bonifacino JS. The molecular machinery for lysosome biogenesis. Bioessays 23: 333-343, 2001.
56. Munoz M, Garcia-Erce JA, and Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homo-eostasis. J Clin Pathol 64: 281-286, 2011.
57. Myung J, Kim KB, and Crews CM. The ubiquitin-protea-some pathway and proteasome inhibitors. Med Res Rev 21: 245-273, 2001.
58. Nilsson E, Ghassemifar R, and Brunk UT. Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress. Histochem J 29: 857-865, 1997.
59. Olejnicka BT, Andersson A, Tyrberg B, Dalen H, and Brunk UT. Beta-cells, oxidative stress, lysosomal stability, and ap-optotic/necrotic cell death. Antioxid Redox Signal 1: 305-315, 1999.
60. Persson HL, Kurz T, Eaton JW, and Brunk UT. Radiation-induced cell death: importance of lysosomal destabilization. Biochem J 389: 877-884, 2005.
61. Pisoni RL, Acker TL, Lisowski KM, Lemons RM, and Thoene JG. A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal prote-olysis. J Cell Biol 110: 327-335, 1990.
62. Podgorski I and Sloane BF. Cathepsin B and its role(s) in cancer progression. Biochem Soc Symp 263-276, 2003.
63. Quintana C, Bellefqih S, Laval JY, Guerquin-Kern JL, Wu TD, Avila J, Ferrer I, Arranz R, and Patino C. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the sub-cellular level. J Struct Biol 153: 42-54, 2006.
64. Richardson DR, Kalinowski DS, Lau S, Jansson PJ, and Lovejoy DB. Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 1790: 702-717, 2009.
65. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Suryo Rahmanto Y, Sheftel AD, and Ponka P. Mi-tochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc Natl Acad Sci USA 107: 10775-10782, 2010.
66. Richardson DR, Sharpe PC, Lovejoy DB, Senaratne D, Ka-linowski DS, Islam M, and Bernhardt PV. Dipyridyl thiose-micarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. J Med Chem 49: 6510-6521, 2006.
67. Roy S and Debnath J. Autophagy and tumorigenesis. Semin Immunopathol 32: 383-396, 2010.
68. Salvador GA, Uranga RM, and Giusto NM. Iron and mechanisms of neurotoxicity. Int J Alzheimers Dis 2011: 720658, 2010.
69. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S, Parenti G, Cattaneo E, and Ballabio A. A gene network regulating lysosomal biogenesis and function. Science 325: 473-477, 2009.
70. Schafer FQ and Buettner GR. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic Biol Med 28: 1175-1181, 2000.
71. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, and Ballabio A. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31: 1095-1108, 2012.
72. Sridhar S, Botbol Y, Macian F, and Cuervo AM. Autophagy and disease: always two sides to a problem. J Pathol 226: 255-273, 2012.
73. Storr SJ, Carragher NO, Frame MC, Parr T, and Martin SG. The calpain system and cancer. Nat Rev Cancer 11: 364-374, 2011.
74. Takagi H, Shi D, Ha Y, Allewell NM, and Theil EC. Localized unfolding at the junction of three ferritin subunits. A mechanism for iron release? J Biol Chem 273: 18685-18688, 1998.
75. Terman A, Abrahamsson N, and Brunk UT. Ceroid/lipo-fuscin-loaded human fibroblasts show increased susceptibility to oxidative stress. Exp Gerontol 34: 755-770, 1999.
76. Terman A and Brunk UT. Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res 68: 355-365, 2005.
77. Terman A, Dalen H, and Brunk UT. Ceroid/lipofuscin-loaded human fibroblasts show decreased survival time and diminished autophagocytosis during amino acid starvation. Exp Gerontol 34: 943-957, 1999.
78. Terman A, Gustafsson B, and Brunk UT. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 163: 29-37, 2006.
79. Terman A, Gustafsson B, and Brunk UT. Autophagy, or-ganelles and ageing. J Pathol 211: 134-143, 2007.
80. Terman A, Kurz T, Gustafsson B, and Brunk UT. Lysosomal labilization. IUBMB Life 58: 531-539, 2006.
81. Terman A, Kurz T, Navratil M, Arriaga EA, and Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. An-tioxid Redox Signal 12: 503-535, 2010.
82. Uchiyama Y, Shibata M, Koike M, Yoshimura K, and Sasaki M. Autophagy-physiology and pathophysiology. Histochem Cell Biol 129: 407-420, 2008.
83. Werneburg NW, Guicciardi ME, Bronk SF, Kaufmann SH, and Gores GJ. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem 282: 28960-28970, 2007.
84. Whitnall M, Howard J, Ponka P, and Richardson DR. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc Natl Acad Sci USA 103: 14901-14906, 2006.
85. Wickman G, Julian L, and Olson MF. How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ 19: 735-742, 2012.
86. Yang Z and Klionsky DJ. Eaten alive: a history of macro-autophagy. Nat Cell Biol 12: 814-822, 2010.
87. Yang Z and Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22: 124-131, 2010.
88. Yeung BH, Huang DC, and Sinicrope FA. PS-341 (bortezo-mib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells. J Biol Chem 281: 11923-11932, 2006.
89. Zhang Y, Mikhael M, Xu D, Li Y, Soe-Lin S, Ning B, Li W, Nie G, Zhao Y, and Ponka P. Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. Antioxid Redox Signal 13: 999-1009, 2010.
90. Zhao M, Antunes F, Eaton JW, and Brunk UT. Lysosomal enzymes promote mitochondrial oxidant production, cyto-chrome c release and apoptosis. Eur J Biochem 270: 3778-3786, 2003.
91. Zhao M, Eaton JW, and Brunk UT. Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2? FEBS Lett 485: 104-108, 2000.